COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
01/02/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
01/02/2018
U.S. Patient Utilization Grew 33%, Year Over Year DANVERS, Mass., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, today [...]
AxoGen, Inc. to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
01/02/2018
ALACHUA, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries , today announced that Karen Zaderej [...]
RedHill Biopharma to Present at BIO CEO & Investor Conference
01/02/2018
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Vical and Mycoses Study Group Education and Research Consortium Establish Collaboration to Advance Vical’s Novel Antifungal VL-2397 for the Treatment of Invasive Aspergillosis
01/02/2018
SAN DIEGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) and the Mycoses Study Group Education and Research Consortium (MSGERC) today announced the establishment of a collaboration to advance [...]
Coloplast delivers solid Q1 interim results and continues to take market share
01/02/2018
Coloplast delivered 8% organic revenue growth and an EBIT margin of 31% at constant exchange rates in the first quarter of the 2017/18 financial year. The results were in line with the company’s guidance. Coloplast [...]
Announcement no. 02/2018 - Q1 Interim Financial Report, 2017/18
01/02/2018
Q1 2017/18 Interim financial report, Q1 2017/18 (01 October 2017 - 31 December 2017) Please see enclosed pdf. Highlights Coloplast generated 8% organic growth in the first quarter. Reported revenue in DKK was up by 5% [...]
Digirad Corporation Announces Quarterly Dividend of $0.055 Per Share
01/02/2018
SUWANEE, Ga., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD ) today announced a quarterly cash dividend of $0.055 per share. The dividend is payable on February 28, 2018 to shareholders of record [...]
JOBST Ranked #1 Physician Recommended Compression Therapy Brand in US
01/02/2018
CHARLOTTE, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- BSN medical , a global provider of integrated medical therapy solutions, today announced that its JOBST ® compression therapy line has been ranked the number one [...]
BIOLIFE4D Launches Regulation A+ (Mini-IPO) Offering; Plans to Raise $50M
01/02/2018
CHICAGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched a Regulation A+ (Mini- [...]
Targovax ASA issues options to employees
01/02/2018
On the basis of the approval by the Annual General Meeting on 5 April 2017 to authorize the Board of Targovax ASA to issue new shares to employees under the Company long-term incentive program, the Board has resolved to [...]
Saniona AB: Saniona's Partner, Medix, Completes Recruitment of Phase 3 Obesity Study of Tesofensine in Mexico
01/02/2018
PRESS RELEASE February 1, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that its partner in Mexico, Medix, has completed recruitment for its Phase 3 clinical study of tesofensine [...]
Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders
01/02/2018
Shire presentations at EAHAD 2018 demonstrate commitment to studying outcomes in patients with bleeding disorders Shire presentations showcase heritage in Hematology Zug, Switzerland - February 1, 2018 - Shire plc (LSE [...]
DBV Technologies to Attend Upcoming Investor Conferences
01/02/2018
Press Release Montrouge, France, February 1, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that members [...]
DBV Technologies to Attend Upcoming Investor Conferences
01/02/2018
Press Release Montrouge, France, February 1, 2018 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that members [...]
Novo Nordisk increased reported operating profit by 1% in 2017 to DKK 49 billion (5% growth in local currencies)
01/02/2018
Reported sales were broadly unchanged at DKK 112 billion (2% growth in local currencies) Sales within diabetes care and obesity increased by 4% to DKK 92.9 billion (7% in local currencies). Sales of Tresiba ® increased [...]
Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma
01/02/2018
SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) announced today that it has received a milestone payment from the Company’s Chinese partner for eftilagimod alpha (IMP321), [...]
Sol-Gel Technologies Ltd. Announces Pricing of Initial Public Offering
01/02/2018
NESS ZIONA, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (“Sol-Gel”) (NASDAQ: SLGL ), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and [...]
Harvard Bioscience Completes Acquisition of Data Sciences International
01/02/2018
HOLLISTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, [...]

Pages